MedPath

A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction

Not Applicable
Completed
Conditions
Malignant Biliary Obstruction
Interventions
Procedure: metallic biliary stent insertion (double bare - S&G Biotech.)
Procedure: metallic biliary stent insertion (single bare - S&G Biotech.)
Procedure: metallic biliary stent insertion (single bare - Taewoong Medical.)
Registration Number
NCT01869894
Lead Sponsor
Yonsei University
Brief Summary

Our study is the prospective randomized study for efficacy of uncovered double bare metallic stent compared to uncovered single bare metallic stent in malignant biliary obstruction

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • The patients who had malignant biliary obstruction
Read More
Exclusion Criteria
  • The patients who had resectable biliary malignancy
  • The patients who had hilar obstruction
  • The patients who had duodenal obstruction
  • The patients who had other malignancy which is not related to biliary obstruction
  • The patients who had uncontrolled infection
  • The patients who had poor performance (ECOG =3 or 4)
  • The patients who were not acquired informed consent
  • The patients who had technically difficult structure for ERCP
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
uncovered double bare metallic stent (S&G Biotech.)metallic biliary stent insertion (double bare - S&G Biotech.)uncovered double bare metallic stent
uncovered single bare metallic stent (S&G Biotech.)metallic biliary stent insertion (single bare - S&G Biotech.)uncovered single bare metallic stent
uncovered single bare metallic stent (Taewoong Medical.)metallic biliary stent insertion (single bare - Taewoong Medical.)uncovered single bare metallic stent
Primary Outcome Measures
NameTimeMethod
Median patency durationApproximately 6 months later since the date of stent insertion

Primary end point : A. Median patency duration

Secondary Outcome Measures
NameTimeMethod
6-months patency rateApproximately 6 months later since the date of stent insertion

Secondary end point : A. 6-months patency rate

Trial Locations

Locations (1)

Severance Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath